تجاوز إلى المحتوى الرئيسي
drug protocol number
BAY43-9006/14295
drug sponsor
Bayer
drug study
Sorafenib
drug trial site
King Faisal Specialist Hospital and Research Center (Riyadh)
drug status
Ongoing
drug phase